| （単位：千ドル） | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|
| 研究開発費 | 33,287 | 61,858 | 105,533 | 196,328 | 265,081 | 150,908 | 79,939 |
| 営業費用 | 45,721 | 91,418 | 157,057 | 271,475 | 322,429 | 196,056 | 122,225 |
| 営業利益 | -45,721 | -91,418 | -157,057 | -271,475 | -322,429 | -196,056 | -122,225 |
| 経常（税引前）利益 | -43,538 | -85,372 | - | - | - | - | - |
| 法人税等合計 | 0 | - | - | - | - | - | - |
| 実効税率（％） | - | - | - | - | - | - | |
| 純利益 | -43,538 | -85,372 | -153,480 | -269,860 | -319,952 | -185,701 | -115,818 |
| 一株あたり利益 | - | - | - | - | -5.06 | -2.14 | -1.3 |
| 希薄化後一株あたり利益 | - | - | - | - | -5.06 | -2.14 | -1.3 |
| EBITDA | -155,557 | -269,175 | -315,329 | -189,956 | -114,525 |